Case report: complete remission with crizotinib in ROS1 fusion-positive sinonasal mucosal melanoma

Case report: complete remission with crizotinib in ROS1 fusion-positive sinonasal mucosal melanoma

IntroductionSinonasal mucosal melanoma (SNMM) originates from melanocytes. Currently, the main treatment methods, including surgery, radiotherapy and chemotherapy, have little effect on the recurrence and metastasis of SNMM. However, targeted therapy may be a breakthrough in treating SNMM.MethodsA S...

Full description

Bibliographic Details
Main Authors: Jun Cao, Yaner Yu, Yangkun Zhou, Qing Ji, Wenkang Qian, Dongdong Jia, Gu Jin, Yajun Qi, Xin Li, Ningning Li, Tao Li, Meiyu Fang, Hongchuan Jin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
crizotinib
ROS1
sinonasal
mucosal melanoma
complete remission
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.942258/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.942258/full

Similar Items